Trial intelligence / Profile preview

Mucoadhesive nifedipine for palatal wound healing after gingival graft surgery

IRCT20190430043431N1Phase 3Completed

Sponsor
Babol University of Medical Sciences
Start
Mar 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, triple-blind trial of nifedipine in gingival recession (2 arms), sponsored by Babol University of Medical Sciences. Primary endpoints: Landry healing index, Manchester scar scale/index and 1 more. Started Mar 2018; status: completed.

02

Drugs

nifedipine
03

Conditions

gingival recession

Beyond the preview

Go deeper on IRCT20190430043431N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190430043431N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call